1. Gözü RO. Pulmoner tromboembolide predispozan faktörler. In: Metintas M, ed. Pulmoner Tromboemboli , Eskisehir: ASD Toraks,2001; 17-20.
2. Topçu F. Acil servisde pulmoner emboliye yaklaşım. Dicle Üniversitesi Tıp Fakültesi Göğüs Hastalıkları ve Tüberküloz Anabilim Dalı. Ders Notları 2012.
3. Uresandia F, Blanquer J, Conget F. Guidelines for the Diagnosis, Treatment, and follow up of Pulmonary Embolism Arch Broncho/pneumol 2004;40:580-594.
4. Genç BÖ. Gülmez İ. Demir ve ark. Pulmoner Tromboemboli’li Hastalarda erken Mortalitede NT-proBNP Değerlerinin Önemi. Türk Toraks Derneği 9.Yıllık Kongresi. Türk Toraks Derneği Sunu Merkezi. 2006.
5. Baydın A. Yardan T. Eden AO ve ark. Acil serviste akut pulmoner emboli tanısı alan olguların incelenmesi. Journal of Academic Emergency Medicine. 2008;7: (1);20-23.
6. Yücel N. ve Yetkin Ö. Acil Serviste Pulmoner Tromboemboli Tanısı Alan Hastaların Retrospektif Olarak Değerlendirilmesi. İnönü Üniversitesi Tıp Fakültesi Dergisi. 2009;16:(4):233-236.
7. Erkan ML. Pulmoner Tromboembolizm. Özel sayısı. Ed.Numan Numanoğlu. Türkiye Klinikleri Göğüs Hastalıkarı2003;(1), 3.
8. Fındık S. Pulmoner Tromboemboli. Çalışma Grupları Eğitim Sunumları. Türkiye Solunum Araştırmalar Derneği 2011.
9. Dalen JE, Alpert JS. Naturel history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:259-70.
10. Robetoyre RS, Rodgers GM. Update on selected inherited venous thrombotic disorders. Am J Hematol 2001;68:256-68.
11. Ryu JH, Olson EJ, Pellikka PA. Clinical recognition of pulmonary embolism: problem of unrecognized and asymptomatic cases. Mayo Clin Proc 1998; 73:873-9.
12. Özsu S, Bülbül Y, Öztuna F, Özlü T. Pulmoner Tromboemboli: Başvuru Kliniği ve Radyografik Özelliklerinin Karşılaştırılması. Akciğer Arşivi: 2006; 7: 6-10.
13. Courtney DM, Kline JA: Identification of prearrest clinical factors associated with outpatient fatal pulmonary embolism. Acad Emerg Med 2001; 8: 1136.[PMID: 11733290].
14. Kurkciyan I, Meron G, Sterz F, et al: Pulmonary embolism as a cause of cardiac arrest. Arch Intern Med 2000; 160: 1529.[PMID: 10826469].
15. Manfredini R, Portaluppi F, Grandi E, et al: Out of hospital sudden death referring to an emergency department. J Clin Epidemiol 1996; 49: 865.[PMID: 8699205].
16. Moser KM. Venous thromboembolism. Am Rev Rspir Dis 1990;141:235- 249.
17. Abakay Ö. Kliniğimizde 2000-2005 yılları arasında yatırılan pulmoner tromboemboli tanılı hastaların retrospektif değerlendirilmesi. Dicle Üniversitesi Tıp Fakültesi Göğüs Hastalıkları ve Tüberküloz Anabilim Dalı. Uzmanlık Tezi, Diyarbakır 2007.
18. Fraser RS, Müler NL, Colman N, Pare PD. Fraser and Pare’s diagosis of diseases of the chest. 4th ed. Pennsylvania; WB Saunders Company,1999;1775- 1835.
19. Lowe G. Epidemiology of postoperative deep vein thrombosis and pulmonary embolism. Seminars in Thrombosis and Hemostasis. 1991;17:247-249.
20. Metintas S. Venöz trombüs ve pulmoner tromboemboli epidemiyelojisi. Metintas M, ed. Pulmoner Tromboemboli , Eskisehir: ASD Toraks,2001; 3-15.
21. Cushman M, Tsai AW, White RH, et al: Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19.[PMID: 15210384].
22. Heit JA: The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Haemost 2006; 21:23.[PMID: 16475038].
23. Schneider D, Lilienfeld DE, Im W, et al: The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. J Natl Med Assoc 2006; 98:1967,.[PMID: 17225843].
24. Stein PD, Kayali F, Beemath A, et al: Mortality from acute pulmonary embolism according to season. Chest 2005; 128: 3156,.[PMID: 16304256].
25. Stein PD, Kayali F, Olson RE: Regional differences in rates of diagnosis and mortality of pulmonary thromboembolism. Am J Cardiol 2004; 93:1194.[PMID: 15110225].
26. Demir T. Pulmoner Emboli. www.ctf.edu.tr/anabilimdallari/pdf/366/ Pulmoner Emboli. pdf Erişim Tarihi: 20.04.2012
27. Progress in Cardiovascular Disease. 1975; XVII, 4
28. Elias A, Colombier D, Victor G, et al. Diagnostic performance of complete lower limb venous ultrasound in patients with clinically suspected acute pulmonary embolism. Thromb Haemost 2004; 91: 187–95.
29. Pulmoner Tromboemboli PTE PE.2011. http://www.draligus.com /1626- pulmoner-tromboemboli-pte-pe.html. Erişim tarihi 16.04.2012.
30. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203-5.
31. Arseven O. Venöz Tromboembolizm. Türk Toraks Derneği 6.Kış Okulu Kitabı 2007; 156-174. 31. Arseven O. Venöz Tromboembolizm. Türk Toraks Derneği 6.Kış Okulu Kitabı 2007; 156-174.
32. Torbicki A, Van Beek EJR, Charbonnier B, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301-36
33. Ogren M, Bergqvist D, Eriksson H, et al. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23796 consecutive autopsies. Eur Heart J 2005; 26; 1108-14.
34. British Thoracic Society. Suspected acute pulmonary embolism: a practical approach. Thorax 1997; 52:1–24.
35. Ercüment E. Akciğer tromboembolisi, In: Özyardımcı N, ed. Nonspesifik Akciğer Hastalıkları Cilt II. Bursa;U.Ü.Basımevi,1999;1011-1025.
36. Mitchell RN, Contran RS. Hemodynamic disorders, thrombosis, and shock. In: Contran RS, ed. Robins pathologic basis of disease. 6 ed. Philadelphia: WB Saunders, 1999; 13-130
37. Isıksoy S. Normal Hemostazis ve Venöz Trombüs Oluşumu. İçinde: Metintas M, (ed). Pulmoner Tromboemboli. Eskisehir, ASD Toraks Yayınları, 2001; 43-63.
38.Heit JA, Mohr DN, Silversitein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160: 761-8.
39. Becattini C, Agnelli G. Pathogenesis of venous thromboembolism. Curr Opin Pulm Med 2002; 8:360-4.
40. Dalen JE. Pulmonary Embolism;Natural History,Pathophysiology, and Diagnosis. Chest 2002; 122:1440-1456.
41. Heijer M, Koster T, Blom J, Bos J, et al. Hyperhomocysteinemia as a Risk Faktor For Deep-Vein Thrombosis. The New England Journal Of Medicine 1996;334:759-762.
42. Kraaijenhagen RA, Anker PS, Koopman MMW et al. High plasma concentration of factor VIIIc is a major risk factors for venous thromboembolism. Thromb Haemost 2000; 83: 5–9.
43. Lensing A, Prandoni P, Prins MH, Büller HR. Deep-Vein Thrombosis. The Lancet 1999; 353:479-485.
44. Sanson BJ, Simioni P, Tormene D et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C or protein S: a prospective cohort study. Blood 1999; 94: 3702–6
45. Tsai W, Cushman M, Rosamond D, et al. Coagulation Factors, Inflammation Markers and Venous Thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology. The American Journal Of Medicine 2002; 113:636- 642.
46. Dahlback B, Carlsson M, Svensson PJ. Proc Natl Acad Sci USA 1993; 90: 1004
47.Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia Part I. Thromb Haemoast 1996; 76 (5): 651-652.
48. Herold CJ, Bankier AA, Burghuber OC, et al. Pulmonary embolism: Pulmonary vascular disorders, vasculitides, and hemorrhage. In: Albert RK. Eds. Comprehensive respiratory medicine. Philadelphia: Mosby,1999; s:1-12.
49. Kolsuz M. Venöz trombüs ve tromboemboli risk faktörleri. In: Metintas M, ed. Pulmoner Tromboemboli , Eskisehir: ASD Toraks,2001; s:21-41.
50. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia Part I. Thromb Haemost 1996;76: 824-834.
51. Tapson VF, Carroll BA, Devidson BL, et al. The diagnostic approach to acute venous thromboembolism. American Thoracic Society Consensus Steatement and Clinical Practice Guidelines. Am J Crit Care Med 1999; 160: 1043-66.
52. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58: 470-84.
53. Bertina RM, Koelman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resitance to activated protein C. Nature. 1994; 369: 64.
54. Tüfek Y. Pulmoner tromboemboli tanısında klinik olasılık testlerinin ventilasyon/perfüzyon sintigrafisi ve/veya pulmoner bt anjiografi bulguları ile karşılaştırılması. Adnan Menderes Üniversitesi Tıp Fakültesi Göğüs Hastalıları Anabilim dalı. Uzmanlık tezi. Aydın. 2008.
55. Piazza G, Goldhaber SZ. Acute pulmonary embolism: Epidemiology and diagnosis. Circulation 2006; 114: 28-32.
56. Kabukcu HK. Ve Ulusan V. Yaşlılarda pulmoner tromboemboli. Geriatri.2003;6: (3); 113-118.
57. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005; 118: 978-80.
58. Tsai AW, Cushman M, Rosamond WD, et all. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002;162:1182-9.
59. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999;82: 610-9.
60. Heit JA, O’Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-8.
61. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007; 44: 62-9.
62. Piccioli A, Falanga A, Baccaglini U, et al. Cancer and venous thromboembolism. Semin Thromb Haemost 2006; 32: 694-9.
63. Lee AYY, Levine MN. Venous thromboembolism and cancer; risk and outcomes. Circulation 2003; 107: 17-21.
64. Otten HM, Mathijssen J, ten Cate H, et al. Symptomatic venous trhromboembolism in cancer patients treated with chemotherapy: An underestimted phenomenon. Arch Intern Med 2004; 164: 190-4.
65. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: Determination of frequency and characteristics. Thromb Haemost 2002; 87: 575-9.
66. Kamphuisen PW, Agnelli G, Sebastianelli M. Prevention of venous thromboembolism after acute ischemic stroke. Thromb Haemost 2005; 3: 1187-94.
67. Stone SE, Morris TA. Pulmonary embolism during and after pregnancy. Crit Care Med 2005; 33: (10 suppl); 294-300.
68. Farmer RDT, Lawrenson RA, Thompson CR, et al. Population based study of risk of venous thromboembolism associated with various oral contraseptives. Lancet 1997; 349: 83-8.
69. Velmahos GC, Kern J, Chan LS, et al. Prevention of venous thromboembolism after injury: an evidence-based report - Part 1: analysis of risk factors and evaluation of the role of vena cava filters. J Trauma 2000; 49: 132-9.
70. Goldhaber S: Pulmonary embolism. N Engl J Med 1998;339:93- 104. 71. Herman AR, Arnsten JH. Diagnosis and treatment of pulmonary embolism in the elderly. Clin Geriatr Med. 2003;19:157-75.
72. Palevsky HI, Kelley MA, Fishman AP. Pulmonary Tromboembolic disease. In: Fishman AP, Elias JA, Fishman AJ, Grippi MA, Kaiser LR, Senior RM, eds. Fishman’s pulmonary disaese and disorders, vol 1. 3 ed. New York: McGraw-Hill, 1998;1297-1331.
73. Task force on pulmonary embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000;21:1301-1336.
74. Eliot CG. Pulmonary physiology during pulmonary embolism. Chest 1992; 101:163-171.
75. Goldhaber SZ, Elliott CG. Acute Pulmonary Embolism: Epidemiology, Pathophysiology and Diagnosis. Circulation 2003;108:2726-9
76. Mainer G, Castaing Y, Guenard H. Determinants of hypoxemia during the acute phase of pulmonary embolism in humans. Am Rev Respir Dis 1985; 132:332- 338.
77. Santolicandro A, Prediletto R, Fornai E, Formichi B, et al. Mechanisms of hypoxemia and hypocapnia in pulmonary embolism. Am J Respir Crit Care Med.1995;152(1):336-47.
78. Boğatekin G. Pulmoner Tromboemboli Tanısında Kullanılan Klinik Olasılık Skorlama Yöntemlerinin Karşılaştırılması. Dicle Üniversitesi Tıp Fakültesi Göğüs Hastalıkları ve Tüberküloz Anabilim Dalı. Uzmanlık Tezi, Diyarbakır 2010.
79. Naeije R, Leeman M. Physiopathology of pulmonary arterial hypertension and gas exchange in acute pulmonary embolism. Rev Mal Respir. 1999;16:877-84.
80. Arseven O, Sevinç C, Alataş F et al. Pulmoner Tromboembolizm Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Dergisi 2009;10:7-37
81. Anderson FA. Wheleer HB. Goldberg RJ. et. al. A population-based perspective of the hospital insidence and case-fatality rates deep vein thrombosis and pulmonary embolism, the Worcester DVT Study. Arch.Intern. Med. 1991:151;933-938.
82. Carson JL, Kelley MA, Duff A. The clinical Course of Pulmonary Embolism. N Engl Med 1992;326:1240-1245
83. Miniati M, Prediletto R, Marini C, et al. Accuracy of clinical assesment in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 1999;159:864-871. 84. Stein PD, Terin ML, Hales CA, et al. Clinical Laboratory, roentgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991;100:598-603.
85. Fedullo PF, Morris TA. Pulmonary Thromboembolism Chapter 48. In: Murray and Nadel’s Textbook of Respiratory Medicine, 4th ed. 2005; 1:1425-58.
86. Erkan L, Fındık S, Öztürk A, ve ark. Masif pulmoner tromboembolide trombolitik tedavi. Solunum Hastalıkları 2002;13:163-171.
87. Mclntyre K, Sasahara A: The ratio of pulmonary arterial pressure to pulmonary vascular obstruction: index of preembolic cardiopulmonary status. Chest 1977:71:692-7.
88. Stein PD, Willis PW III, De Mets DL. History and physician examination in acute pulmonary embolism in patients without pre-existing cardiac and pulmonary diseases. Ann Cardiol 1981;47:218-223.
89. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: Management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-Dimer. Ann Intern Med 2001;135:98-107.
90. Wicki J, Pergener TV, Junod AF, et al. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score Arch Intern Med 2001;161:92-97.
91. PIOPED investigators. The value of the ventilation/ perfusion scan in acute pulmonary embolism:results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 263: 2753-9.
92. Wells PS, Ginsberg JS, Anderson DR, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998; 129:997-1005.
93. Perrier A, Miron MJ, Desmarais S et al. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower limb venous compression ultrasonography? Arch Int Med 2000;160:512-6.
94. Yung GL, Fedullo PF. Disorders of the pulmonary circulation Part IX; Pulmonary Thromboembolic Disease in: Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, eds. Fishman’s Pulmonary Diseases and Disorders. 4th ed. Philadelphia: 2008; 2:1423-1447.
95. Burke B, Sostman HD, Carroll BA, Wihitty LA. The diagnostic aproach to deep venous thrombosis. Which technique. In: Tapson VF. eds. Venous thromboembolism. Clin Chest Med 1995;16:253- 268.
96. Powell T, Müler NL. Imaging of acute pulmonary tromboembolism: should spinal computed tomography replace the ventilation perfusion scan. Clin Chest Med 2003; 24: 29-38.
97. Worsley DF, Alavi A, Aronchick JM, et al. Chest radiographic findings in patients with acute pulmonary embolism: observations from the PIOPED study. Radiology 1993;189:133-136.
98. Stein PD, Athanasoulis C, Greenspan RH, Henry JW. Relation of plain chest radiographic findings to pulmonary arterial pressure and arterial blood oxygen levels in patients with acute pulmonary embolism. Am J Cardiol 1992;69:394-396.
99. Elgazzar AH. Scintigraphic diagnosis of pulmonary embolism: unraveling the confusion seven years after PIOPED. Nucl Med Ann 1997;69-101.
100. Polak JF, Mc Neil BJ. Pulmonary scintigraphy and the diagnosis of pulmonary embolism: perspective. Clin Chest Med 1984;5:457-464.
101.Light RW. Peural diseases. Lippincott Williams & Wilkins Philadelphia, 2001:pp:219-225. 70. Polak JF, Mc Neil BJ. Pulmonary scintigraphy and the diagnosis of pulmonary embolism: a perspective. Clin Chest Med 1984;5:457-464.
102. Hull RD, Raskob GE, Coates G et al. A new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med 1989;149:2549-55.
103. Worsley DF, Alavi A. Comprehensive analysis of the results of the PIOPED study. Prospective Investigation of Pulmonary Embolism Diagnosis Study. J Nucl Med 1995; 36: 2380-7.
104. Altintop L, Yardan T, Cander B et al. An increase of BNP levels in massive pulmonary embolism and the reduction in response to the acute treatment. Resuscitation 2005;65(2): 225–9.
105. Çildağ MB. Pulmoner Tromboemboli Tanısında Spiral Bilgisayarlı Tomografik Pulmoner Anjiografinin Yeri; Klinik ve Laboratuar Verileri İle Uyumu.
Adnan Menderes Üniv. Tıp Fak. Radyodiagnostik Anabilim dalı, Uzmanlık Tezi. Aydın 2006.
106. Herold CJ. Spiral computed tomography of pulmonary embolism.Eur Respir J 2002;19: Supp 35:13-21.
107. Musset D, Parent F, Meyer G, Maitre S, Girard P, Leroyer C et al. Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet 2002;360:1914–1920.
108. Perrier A, Roy PM, Aujesky D, Chagnon I, Howarth N, Gourdier AL et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004;116:291–299.
109. Ghaye B, Szapiro D, Mastora I, Delannoy V, Duhamel A, Remy J et al. Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology 2001;219:629–636.
110.Patel S, Kazerooni EA, Cascade PN. Pulmonary embolism: optimization of small pulmonary artery visualization at multi-detector row CT. Radiology 2003;227:455–460.
111. Remy-Jardin M, Remy J, Wattinne L, Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique— comparison with pulmonary angiography. Radiology 1992;185:381–387. 112. Stein PD, Fowler SE, Goodman LR, et all. Multi-detector computed tomography for acute pulmonary embolism. N Engl J Med 2006; 354: 2317-27.
113. Stein PD, Athenasoulis C, Alavi A, et al. Complications and Validity of Pulmonary Angiography in Acute Pulmonary Embolism. Circulation 1992; 85:462- 468.
114. Stein PD, Henry JW, Gottschalk A. Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: relation of interpreter agreement to the order of the involved pulmonary arterial branch. Radiology 1999; 210: 689-91.
115. Wells PS, Rodger M. Diagnosis of pulmonary embolism: when is imaging needed? Clin Chest Med 2003; 24: 13-28.
116. Kaya T. Pulmoner Tromboemboli Tanısında Anjiografi. Metintaş M, (ed). Pulmoner Tromboemboli. Eskişehir, ASD Toraks Yayınları,2001:129-135.
117. Geibel A, Zehender M, Kaser W, et al. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. Eur Respir J 2005; 25: 843-8.
118. Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002;136:91-700.
119. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: Clinical Outcomes in the International Cooparative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-9.
120. Konstatinides S, Geibel A, Olschewski M et al. Association Between Thrombolytic Treatment and the Prognosis of Hemodynamically Stable Patients with Major Pulmonary Embolism: Results of a Multicenter Registry. Circulation 1997; 96:882-888.
121. Söhne M, Wolde M, Büller HR, et al. Biomarkers in Pulmonary Embolism. Current Opinion in Cardiology 2004;19:558-562.
122. Pruszczyk P, Torbicki A, Kuch-Wocial A, et al. Transoesophageal echocardiography for definitive diagnosis of haemodynamically significant pulmonary embolism. Eur Heart J 1995; 16: 534-8.
123. Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no preexisting cardiac or pulmonary disease. Chest 1991; 100: 598- 603.
124. Kline JA, Hernandez-Nino J, Newgard CD, et al. Use of pulse oximetry to predict in-hospital complications in normotensive patients with pulmonary embolism. Am J Med 2003; 115: 203-8.
125. Kearon C, Ginsberg JS, Douketis J, et al. Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) Group. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med 2006; 144: 812-21.
126. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R et al. D-dimer for the Exclusion of Acute Venous Thrombosis and Pulmonary Embolism: a Systematic Review. Ann Intern Med 2004;140:589–602.
127. Kelly J, Rudd A, Lewis RR, Hunt BJ. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med 2002;162:747-56.
128. Brown MD, Lau J, Nelson RD, Kline JA. Turbidimetric D-dimer test in the diagnosis of pulmonary embolism: a metaanalysis. Clin Chem 2003; 49:1846-53.
129. Brown MD, Rowe BH, Reeves MJ, et al. The accuracy of the enzyme- linked immunosorbent assay D-dimer test inthe diagnosis of pulmonary embolism: a meta analysis. Ann Emerg Med 2002; 40:133-44.
130. Ginsberg JS, Wells PS, Kearon C, et al. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med 1998; 129: 1006-11.
131. Lee AY, Hirsh J. Diagnosis and treatment of venous thromboembolism. Annu Rev Med 2002; 53:15-33.
132. Lensing AWA, Büller HR. Objective tests for the diagnosis of venous thrombosis. In: Hull RD, Pineo GF (eds). Disorders of thrombosis. Philadelphia: Saunders, 1996;239-57.
133. Topson VF. Pulmonary Embolism: In: Fuster V, Alexander RW, O’Rourke RA, (eds), Hurst’s The Heart (10th ed). Vol. 2. New York, McGraw-Hill Co, 2001; 1625-1643.
134. Dorfman GS, Cronan JJ. Venous ultrasonogaphy. Radiol Clin North Am 1992;30:879- 94.
135. Evans AJ, Sostman HD, WittyLA, et al. Prospective evaluation of MR and sonography. J Mag Reson Imaging 1996; 1:44-51.
136. Carpenter JP, Holland GA, Baum RA, et al. Magnetic resonance venography for the detection of deep venous thrombosis: comparis with contrast venography and duplex Doppler ultrasonography. J Vasc Surg 1993; 18:734-741.
137. Gupda A, Frazer CK, Ferguson MJ, et al. Acute Pulmonary Embolism: Diagnosis with MR- Anjiography Radiology 1999; 210:353-359.
138. Beccatini C, Vedovati MC, Angelli G. Prognostic value of troponins in acute pulmonary embolism: a meta analysis. Circulation 2007; 116: 427-33.
139. Hughes D, Talwar S, Squire IB, et al. An immunoluminometric assay for Nterminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction. Clin Sci 1999; 96: 373-80.
140. Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 2003; 123: 1947-52.
141. Cavallazi R, Nair A, Vasu T, Marik PE. Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Medicine 2008; 34: 2147- 56
142. Kruger S, Graf J, Kunz D, et al. BNP levels predict functional capacity in patients with chronic heart failure. Am Coll Cardiol 2002; 40: 718-22.
143.Kline JA, Nelson RD, Jackson RE, Courtney DM: Criteria for the safe use of D-dimer testing in emergency department patients with suspected pulmonary embolism: a multicenter United States study. Ann Emerg Med 2002; 39: 144.[PMID: 11823768]
144. Ten Wolde M, Tulvski I, Mulder M, et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003;107:2082-4.
145. Grifoni S, Olivotto I, Cecchini P,et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101: 2817-22.
146. Brill-Edwards P, Ginsberg JS, Jhonston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993; 119: 104-9.
147. Harold IP, Mark AK, Alfred PF. Pulmonary thromboembolic disease. in: Fishman AP(ed). Fishman’s Pulmonary Disease and Disorders. (ed): AP Fishman. Mc GrawHill 1998;1297-1329.
148. Raschke RA, Reilly BM, Guidry JR, et al. The weight-based heparin dosing nomogram compared with a Standard care nomogram: A randomised controlled trial. Ann Intern Med 1993; 119: 874-81.
149. Quinlan DJ, McQuinlan A, Eikelboom JW. Low-molecularweight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism. A metaanalysis of randomized, controlled trials. Ann Intern Med 2004; 140: 175-83.
150. Kearon C, Kahn SR, Agnelli K, et al. Antithrombotic therapy for venous thromboembolic disease. ACCP evidence based clinical practice guidelines (8th Edition).Chest 2008; 133: 454-545.
151. Merli G, Spiro TE, Olsson CG, et al. Sub- cutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 2001; 134: 191-202.
152. Weitz J, Hirsh J, et al. New anticoagulant drugs. Chest 2001;119(suppl): 95-107.
153. Arcasoy S, Kreit J: Thrombolytic therapy of pulmonary embolism. Chest 1999;115:1695-707.
154. Konstantinides S. Acute pulmonary embolism. N. Eng J Med 2008: 359; 2804-13.
155. Decousus H, Leizorov A, Parent F, et al. A clinical trial of vena cava filters